Series C - Protagonist Therapeutics - Jul 16, 2015 Funding Round Profile - Cointime

Bitcoin $90,976.90 -4.23%
Ethereum $3,302.57 -5.18%
BNB $610.80 -5.14%
Optimism $2.18 -7.58%
Arbitrum $0.86 -9.20%
Solana $229.36 -4.19%
Polygon $0.52 -9.50%
Cosmos $7.87 -2.80%
Avalanche $41.59 -2.53%

Bitcoin $90,976.90 -4.23%
Ethereum $3,302.57 -5.18%
BNB $610.80 -5.14%
Optimism $2.18 -7.58%
Arbitrum $0.86 -9.20%
Solana $229.36 -4.19%
Polygon $0.52 -9.50%
Cosmos $7.87 -2.80%
Avalanche $41.59 -2.53%

Protagonist Therapeutics

company

Funding Round

Series C

Money Raised

$ 40M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Pharmstandard International	-	-	-	Detail
Inbio Ventures	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Jun 4, 2013	Series B	$ 14M	Inbio Ventures	Detail